Jyong Biotech Ordinary Shares Statistics Share Statistics Jyong Biotech Ordinary Shares has 74.23M
shares outstanding. The number of shares has increased by null%
in one year.
Shares Outstanding 74.23M Shares Change (YoY) n/a Shares Change (QoQ) n/a Owned by Institutions (%) n/a Shares Floating n/a Failed to Deliver (FTD) Shares 33,589 FTD / Avg. Volume 14.4%
Short Selling Information The latest short interest is 144.07K, so 0.19% of the outstanding
shares have been sold short.
Short Interest 144.07K Short % of Shares Out 0.19% Short % of Float 0.33% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -254.6 and the forward
PE ratio is null.
Jyong Biotech Ordinary Shares's PEG ratio is
8.1.
PE Ratio -254.6 Forward PE n/a PS Ratio 0 Forward PS n/a PB Ratio -21.05 P/FCF Ratio -212.1 PEG Ratio 8.1
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Jyong Biotech Ordinary Shares.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 0.02,
with a Debt / Equity ratio of -0.5.
Current Ratio 0.02 Quick Ratio 0.02 Debt / Equity -0.5 Debt / EBITDA -9.73 Debt / FCF -5 Interest Coverage -1.99
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-97.39K Employee Count 31 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by null% in the
last 52 weeks. The beta is 0, so Jyong Biotech Ordinary Shares's
price volatility has been lower than the market average.
Beta 0 52-Week Price Change n/a 50-Day Moving Average 31.39 200-Day Moving Average n/a Relative Strength Index (RSI) 71.89 Average Volume (20 Days) 233,216
Income Statement
Revenue n/a Gross Profit n/a Operating Income -2.06M Net Income -3.02M EBITDA -1.86M EBIT -1.98M Earnings Per Share (EPS) -0.04
Full Income Statement Balance Sheet The company has 98K in cash and 18.14M in
debt, giving a net cash position of -18.04M.
Cash & Cash Equivalents 98K Total Debt 18.14M Net Cash -18.04M Retained Earnings -33.08M Total Assets n/a Working Capital n/a
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -3.62M
and capital expenditures 0, giving a free cash flow of -3.62M.
Operating Cash Flow -3.62M Capital Expenditures n/a Free Cash Flow -3.62M FCF Per Share -0.05
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
